Obesity Clinical Trial
Official title:
Secretin Increases Glucose Uptake in Human Brown Adipose Tissue and Induces Satiation.
15 healthy males will be studied with PET/CT, using FDG to investigate glucose metabolism,
and radiowater to investigate perfusion. One scan will be performed in controlled cold
exposure, to see whether subjects have cold activated brown adipose tissue. Two scans will be
performed in room temperature conditions, where all subjects are blinded and randomised to
receive placebo and secretin hydrochloride. PET/CT scans will be analysed blinded.
20 healthy males will also be studied with fMRI, in order to investigate brain activity
responses to appetizing versus bland foods. This study will be conduced on the same patients
as the PET/CT study, but additional subjects with same inclusion and exclusion criteria will
be recruited. Two fMRI scans will be performed in room temperature conditions, where all
subjects are blinded and randomised to receive placebo and secretin hydrochloride. fMRI scans
will be analysed blinded.
The PET/CT study will consist of 15 healthy, normal weight males, between ages 18-65. A
2-hour oral glucose tolerance test is performed on screening day. Calorimetry data is
collected at baseline (resting and fasting) condition.
Three PET/CT scans on three different days will be performed to all 15 study subjects.
Radiowater (15O)-H2O is used to study perfusion and FDG ((F18)-FDG) to study glucose
metabolism. After radiowater, PET data is collected from the neck area for 6 minutes. After
FDG, PET data is collected for 40 minutes on the neck area, 15 minutes on the chest, 15
minutes on the abdomen and 15 minutes on the brain. Calorimetry is collected during the
entire scan. Blood samples are collected during scans for metabolites and for a plasma
activity curve.
One scan is performed during controlled, cold exposure. This is done to investigate, whether
patients have cold activated brown adipose tissue. After this, subjects will undergo two room
temperature condition scans on different days, where participants are single-blinded and
randomised to receive placebo (saline) or secretin (secretin hydrochloride) infusions. All
scans are done in fasting conditions. After subjects have fed at the PET centre, calorimetry
data is collected on all days.
A full body MRI will be performed on a separate day with the Dixon-method.
After scanning visits, brown adipose tissue biopsies will be taken from volunteers by a
plastic surgeon. These samples are analysed in Munich.
Dynamic scan data is analysed with the Carimas program, using Patlak plot. Analysis is
performed blinded. Further statistics analysis is done with SPSS.
The fMRI study will consist of 20 healthy, normal weight males, between ages 18-65. Subjects
who underwent PET/CT scanning will be recruited for this study, as well as an additional
group of subjects with the same inclusion and exclusion criteria. A 2-hour oral glucose
tolerance test is performed on screening day for additional subjcts.
Two fMRI scans are conducted in room temperature after overnight fast on separate days.
Subjects are randomized and blinded to receive placebo and secretin hydrochloride on separate
days. Data on brain activity while viewing appetizing versus bland food images is collected
during scan. After scanning subjects are given a meal and then followed up for two hours.
Data on subjective satiety will be collected with a visual analogue scale questionnaire on
nine different timepoints during the day: in preprandial, prandial and postprandial
conditions.
Functional MRI data is analyzed with Matlab. Analysis is performed blinded. Satiety score is
analzed with SPSS.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |